全文获取类型
收费全文 | 49350篇 |
免费 | 3843篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 395篇 |
儿科学 | 2090篇 |
妇产科学 | 1472篇 |
基础医学 | 6494篇 |
口腔科学 | 522篇 |
临床医学 | 6681篇 |
内科学 | 9259篇 |
皮肤病学 | 781篇 |
神经病学 | 4878篇 |
特种医学 | 1060篇 |
外国民族医学 | 38篇 |
外科学 | 4761篇 |
综合类 | 532篇 |
一般理论 | 99篇 |
预防医学 | 7160篇 |
眼科学 | 669篇 |
药学 | 2639篇 |
中国医学 | 85篇 |
肿瘤学 | 3698篇 |
出版年
2023年 | 456篇 |
2022年 | 620篇 |
2021年 | 1537篇 |
2020年 | 924篇 |
2019年 | 1458篇 |
2018年 | 1695篇 |
2017年 | 1230篇 |
2016年 | 1303篇 |
2015年 | 1383篇 |
2014年 | 1926篇 |
2013年 | 2805篇 |
2012年 | 3977篇 |
2011年 | 4089篇 |
2010年 | 2170篇 |
2009年 | 1893篇 |
2008年 | 3417篇 |
2007年 | 3385篇 |
2006年 | 3122篇 |
2005年 | 3048篇 |
2004年 | 2742篇 |
2003年 | 2452篇 |
2002年 | 2300篇 |
2001年 | 304篇 |
2000年 | 205篇 |
1999年 | 317篇 |
1998年 | 459篇 |
1997年 | 346篇 |
1996年 | 294篇 |
1995年 | 306篇 |
1994年 | 260篇 |
1993年 | 230篇 |
1992年 | 146篇 |
1991年 | 153篇 |
1990年 | 144篇 |
1989年 | 119篇 |
1988年 | 124篇 |
1987年 | 91篇 |
1986年 | 107篇 |
1985年 | 121篇 |
1984年 | 118篇 |
1983年 | 110篇 |
1982年 | 125篇 |
1981年 | 161篇 |
1980年 | 107篇 |
1979年 | 71篇 |
1978年 | 60篇 |
1977年 | 60篇 |
1976年 | 62篇 |
1974年 | 59篇 |
1972年 | 55篇 |
排序方式: 共有10000条查询结果,搜索用时 329 毫秒
991.
Bauermeister José A. Tingler Ryan C. Dominguez Clara Dunne Eileen F. Hoesley Craig Ho Ken Johnson Sherri Lucas Jonathan Macagna Nicole Brown Elizabeth Gundacker Holly Peda Melissa Jacobson Cindy E. Kramzer Lindsay Singh Devika Dezzutti Charlene S. Ayudhya Ratiya Pamela Kunjara Na Marzinke Mark A. Piper Jeanna Devlin Bríd Nuttall Jeremy McGowan Ian Hendrix Craig W. Cranston Ross D. 《AIDS and behavior》2022,26(5):1333-1346
AIDS and Behavior - This study describes the acceptability of a rectal microbicide gel formulation using dapivirine (DPV) among men and women from two countries (United States and Thailand)... 相似文献
992.
Reed Elizabeth West Brooke S. Frost Elizabeth Salazar Marissa Silverman Jay G. McIntosh Craig T. Gómez María Gudelia Rangel Urada Lianne A. Brouwer Kimberly C. 《AIDS and behavior》2022,26(10):3210-3219
AIDS and Behavior - Economic vulnerability is often reported to underlie involvement in sex work among female sex workers (FSW), but may also create urgency in women’s work, limiting... 相似文献
993.
Tolley Elizabeth E. Hamilton Erica L. Eley Natalie Maragh-Bass Allysha C. Okumu Eunice Balán Iván C. Gamble Theresa Beyrer Chris Remien Robert 《AIDS and behavior》2022,26(9):3119-3130
AIDS and Behavior - Adherence to care and antiretroviral therapy is challenging, especially for people living with HIV (PLWH) with additional co-occurring risk factors. Case management... 相似文献
994.
Atujuna Millicent Montgomery Elizabeth T. Hartmann Miriam Ndwayana Sheily Browne Erica N. Sindelo Siyaxolisa Bekker Linda-Gail Minnis Alexandra M. 《AIDS and behavior》2022,26(5):1618-1632
AIDS and Behavior - While pre-exposure prophylaxis (PrEP) is a key HIV prevention tool for adolescents and young adults (AYAs), its initiation and sustained use is shaped by AYAs’ unique... 相似文献
995.
Rachel Elizabeth Ann Fincham Francesca Romana Delvecchio Michelle R Goulart Joe Poe Sheng Yeong Hemant M Kocher 《World journal of gastroenterology : WJG》2021,27(24):3483-3501
Pancreatic cancer remains one of medicine’s largest areas of unmet need. With five-year survival rates of < 8%, little improvement has been made in the last 50 years. Typically presenting with advance stage disease, treatment options are limited. To date, surgery remains the only potentially curative option, however, with such late disease presentation, the majority of patients are unresectable. Thus, new therapeutic options and a greater understanding of the complex stromal interactions within the tumour microenvironment are sorely needed to revise the dismal outlook for pancreatic cancer patients. Natural killer (NK) cells are crucial effector units in cancer immunosurveillance. Often used as a prognostic biomarker in a range of malignancies, NK cells have received much attention as an attractive target for immunotherapies, both as cell therapy and as a pharmaceutical target. Despite this interest, the role of NK cells in pancreatic cancer remains poorly defined. Nevertheless, increasing evidence of the importance of NK cells in this dismal prognosis disease is beginning to come to light. Here, we review the role of NK cells in pancreatic cancer, examine the complex interactions of these crucial effector units within pancreatic cancer stroma and shed light on the increasingly attractive use of NK cells as therapy. 相似文献
996.
Xu Kathryn Sengupta Jay Casey Susan Peltier Joel Stahl Wyatt Peterson Neal Settimi David Taylor Andrew Kippola James Steele Elizabeth Hauser Robert 《Journal of interventional cardiac electrophysiology》2022,63(1):133-142
Journal of Interventional Cardiac Electrophysiology - Ablation index (AI) is a radiofrequency lesion quality marker. The AI value that allows effective and safe pulmonary vein isolation (PVI) is... 相似文献
997.
Jensen Elizabeth A. Young Jonathan A. Kuhn Jaycie Onusko Maria Busken Joshua List Edward O. Kopchick John J. Berryman Darlene E. 《Pituitary》2022,25(1):116-130
Pituitary - Growth hormone (GH) has an important role in intestinal barrier function, and abnormalities in GH action have been associated with intestinal complications. Yet, the impact of altered... 相似文献
998.
Lin Li Elizabeth B. Andrews Xinyu Li Zoran Doder Evgeny Zalmover Kristen Sharma Juliana H. Oliveira Juhaeri Juhaeri Chuntao Wu 《Journal of diabetes and its complications》2021,35(7):107932
Diabetic ketoacidosis (DKA) is a common complication of type 1 diabetes mellitus (T1DM). We found that the incidence of DKA was 55.5 per 1000 person-years in US commercially insured patients with T1DM; age-sex-standardized incidence decreased at an average annual rate of 6.1% in 2018–2019 after a steady increase since 2011. 相似文献
999.
Katherine D. Westreich Scott Isom Jasmin Divers Ralph D'Agostino Jean M. Lawrence Roopa Kanakatti Shankar Lawrence M. Dolan Giuseppina Imperatore Dana Dabelea Elizabeth J. Mayer-Davis Amy K. Mottl 《Journal of diabetes and its complications》2021,35(2):107768
AimsWe sought to characterize the direction and associated factors of eGFR change following diagnosis of youth-onset type 1 and type 2 diabetes.MethodsWe assessed the direction of eGFR change at two visits (mean 6.6 years apart) in SEARCH, a longitudinal cohort study of youth-onset type 1 and type 2 diabetes. We used the CKiDCr-CysC equation to estimate GFR and categorized ‘rising’ and ‘declining’ eGFR as an annual change of ≥3 ml/min/1.73 m2 in either direction. Multivariable logistic regression evaluated factors associated with directional change in eGFR.ResultsEstimated GFR declined in 23.8% and rose in 2.8% of participants with type 1 diabetes (N = 1225; baseline age 11.4 years), and declined in 18.1% and rose in 15.6% of participants with type 2 diabetes (N = 160; baseline age 15.0 years). Factors associated with rising and declining eGFR (versus stable) in both type 1 and type 2 diabetes included sex, age at diagnosis, baseline eGFR and difference in fasting glucose between study visits. Additional factors in type 1 diabetes included time from baseline visit, HbA1c and body mass index.ConclusionsOver the first decade of diabetes, eGFR decline is more common in type 1 diabetes whereas eGFR rise is more common in type 2 diabetes. 相似文献
1000.
Bijay Vaidya Brian K Shenton Susan Stamp Margaret Miller Elizabeth Baister Christopher D Andrews A Jane Dickinson Petros Perros Pat Kendall-Taylor 《Thyroid》2005,15(9):1073-1078
Thyroid-associated ophthalmopathy (TAO) is thought to be a T-cell-mediated autoimmune disorder. We sought to characterize abnormalities in the peripheral blood T-cell subsets in patients with TAO, and examine whether the long-acting somatostatin analogue, octreotide-LAR, treatment affects these cells. We analyzed peripheral blood T-cell subsets by flow cytometry in 26 euthyroid patients with moderately severe active TAO and 24 controls. Twenty-five of the patients with TAO were enrolled in a randomized trial to receive either 30 mg of octreotide-LAR (n = 11) or placebo (n = 14) every 4 weeks for 16 weeks; all 25 patients subsequently received octreotide-LAR 30 mg every 4 weeks from week 16 to 32. T-cell subsets were analysed at baseline, week 16, and week 32. At baseline, the relative percentage of CD4+ helper T-cells (p = 0.0003) and the CD4+/CD8+ ratio (p = 0.008) were significantly higher in patients with TAO compared to controls. Patients with TAO had higher na?ve active T cells (CD45RA+, CD45RA+ CD4+) and lower memory T cells (CD45RO+, CD45RO+ CD4+) than controls. At weeks 16 and 32, there were no significant differences in any T-cell subsets between the octreotide-LAR-treated and placebo groups. These results support a role of T cell in the pathogenesis of TAO, and show that octreotide-LAR has no effect on T-cell subsets during 32-weeks of treatment. 相似文献